• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 787-795.DOI: 10.3969/j.issn.1671-2587.2026.05.018

Previous Articles     Next Articles

Role of Dysregulated Lipid Metabolism in Immune Cell in Inflammatory Diseases and Its Therapeutic Prospects

CHEN Mengke, XIA Rong   

  1. Department of Transfusion Medicine, Huashan Hospital, Fudan University, Shanghai 200040
  • Received:2026-09-02 Revised:2026-09-22 Online:2026-10-20 Published:2026-11-11

Abstract: Dysregulated immune cell lipid metabolism is a critical link between metabolic homeostasis and the development and progression of immune-mediated inflammation. Lipid metabolism comprises fatty acid, cholesterol, sphingolipid, and phospholipid metabolism. Dysregulation of these metabolic processes can remodel immune cell membrane architecture and signaling platforms, thereby amplifying inflammatory signaling, promoting reactive oxygen species (ROS) accumulation, impairing phagocytosis and migratory functions, and disrupting immune cell functional states. Collectively, these alterations contribute to the development and progression of autoimmune diseases and other chronic inflammatory disorders. Emerging evidence further indicates that metabolic pathways and immune homeostasis are interconnected through complex spatiotemporal regulatory networks, and that distinct immune cell types and subsets exhibit pronounced metabolic heterogeneity. These features complicate the identification of key metabolic targets and the prediction of therapeutic responses. Meanwhile, therapeutic strategies targeting key lipid metabolic pathways have shown therapeutic potential, including statins and PCSK9 inhibitors, modulation of the LXR, AMPK, and PPARγ signaling, and inhibition of fatty acid synthesis-related pathways. Such interventions may alleviate metabolic dysregulation, reshape the immune microenvironment, and therefore mitigate inflammatory responses. In this review, we summarize the mechanisms by which immune cell lipid metabolism dysregulation contributes to inflammatory diseases, review current advances and translational applications of lipid metabolism-targeted interventions, and discuss key scientific questions and future research directions. These insights may inform precision interventions and individualized treatment of inflammatory diseases.

Key words: Immune cell, Lipid metabolism, Immunometabolism, Inflammatory diseases, Metabolic imbalance, Therapeutic strategies

CLC Number: